Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. 1985

J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex

Antibodies from the serum of patients with the acquired immune deficiency syndrome (AIDS) or with the AIDS-related complex and from the serum of seropositive healthy homosexuals, recognize two major glycoproteins in cells infected with human T-cell lymphotropic virus type III (HTLV III). These glycoproteins, gp160 and gp120, are encoded by the 2.5-kilobase open reading frame located in the 3' end of the HTLV-III genome, as determined by amino terminus sequence analysis of the radiolabeled forms of these proteins. It is hypothesized that gp160 and gp120 represent the major species of virus-encoded envelope gene products for HTLV-III.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014415 Tunicamycin An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.

Related Publications

J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
May 1984, Science (New York, N.Y.),
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
May 1985, Science (New York, N.Y.),
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
January 1983, AIDS research,
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
January 1985, Nature,
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
January 1987, Haematology and blood transfusion,
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
August 1984, Lancet (London, England),
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
September 1985, Cancer research,
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
September 1985, The West Virginia medical journal,
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
July 1985, Cell,
J S Allan, and J E Coligan, and F Barin, and M F McLane, and J G Sodroski, and C A Rosen, and W A Haseltine, and T H Lee, and M Essex
May 1986, British medical journal (Clinical research ed.),
Copied contents to your clipboard!